Injury Rates Cloud Study on Transvaginal Mesh DeviceSep 17, 2013
New research has revealed that women undergoing treatments for pelvic organ prolapse are unlikely to see any benefits from a transvaginal mesh implant compared with traditional surgery to repair damage.
According to a report at empr.com on a new study appearing in the journal Obstetrics & Gynecology, women who had a transvaginal mesh device implanted to treat their pelvic organ prolapse showed no more signs of improvement than women who underwent traditional surgery, used long before the introduction of transvaginal mesh devices. The study was conducted by researchers at Georgetown University.
For the study, 33 women who had a transvaginal mesh device implanted and 32 who underwent traditional surgery were evaluated over a three-year timeframe. The cure rates were analyzed to determine if women were better off with the transvaginal mesh or the more tested surgery. According to the empr.com report, the study was halted early after several women who had a transvaginal mesh device had experienced mesh exposure.
Based on our numerous reports on the dangers of transvaginal mesh, mesh erosion through the vaginal wall is a main problem with this option to treat pelvic organ prolapse compared with more traditional surgical methods. Thousands of women who've had transvaginal mesh devices implanted have filed lawsuits against their manufacturers seeking damages for the injuries they have suffered.
Our reports show that women implanted with transvaginal mesh are more likely to suffer severe pain, excessive bleeding, infections, organ perforation, urinary problems and pain during sexual intercourse. Many women will have to undergo revision surgery – an often complicated, risky procedure – to repair the damage caused by the transvaginal mesh implant, too.